RNAC vs WELL · P/E 2.1, rev $38.9M vs P/E 100, rev $10.84B
Cartesian Therapeutics Inc. (RNAC) versus Welltower Inc (WELL) — a side-by-side from cached financials, not a winner call.
Cartesian Therapeutics Inc. (RNAC) is a biotechnology company listed on US.
Welltower Inc (WELL) is a reit - healthcare facilities company listed on NYSE.
Latest reported RNAC revenue for 2024-12-31 was $38.9M. Net income was -$77.4M. Revenue was up 49.6% from 2023-12-31 to 2024-12-31. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
Latest reported WELL revenue for 2025-12-31 was $10.84B. Net income was $936.8M. Revenue was up 35.6% from 2024-12-31 to 2025-12-31. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
RNAC currently screens at market cap $290.9M and trailing P/E 2.1. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
Not investment advice. Open the RNAC and WELL stock pages for the full models.
Not investment advice.